Cleared Traditional

K060573 - BURBANK TENACULUM

K060573 is an FDA 510(k) clearance for BURBANK TENACULUM, manufactured by Vascular Control Systems, Inc.. The device is a Class 2 Obstetrics & Gynecology device with product code HDC cleared through the Traditional 510(k) pathway after a 46-day FDA review.

K060573 · Vascular Control Systems, Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2006
Decision
46d
Days
Class 2
Risk

K060573 is an FDA 510(k) clearance for the BURBANK TENACULUM. Classified as Tenaculum, Uterine (product code HDC), Class II - Special Controls.

Submitted by Vascular Control Systems, Inc. (San Juan Capistrano, US). The FDA issued a Cleared decision on April 21, 2006 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.4530 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K060573

510(k) Number K060573 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 2006
Decision Date April 21, 2006
Days to Decision 46 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
115d faster than avg
Panel avg: 161d · This submission: 46d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

HDC Device Classification - Class 2, Special Controls

Product Code HDC Tenaculum, Uterine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.4530
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Tuv Rheinland of North America, Inc.
TAMAS BORSAI

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HDC Tenaculum, Uterine

All 19
Devices cleared under the same product code (HDC) and FDA review panel - the closest regulatory comparables to K060573.
JARIT HULKA UTERINE TENACULUM FORCEPS
K082349 · J. Jamner Surgical Instruments, Inc. · Nov 2008
GYN DISPOSABLES TENACULUM 356T
K073182 · Gyn-Disposables, Inc. · Nov 2007
FEMTEN CERVICAL TENACULUM
K062563 · Fem Suite, LLC · May 2007
TRANSVAGINAL ULTRASOUND PROBE HOLDER SYSTEM
K032585 · Ron-Tech Medical , Ltd. · Jan 2004
BURBANK TENACULUM, MODEL 09-0011-01
K030078 · Vascular Control Systems, Inc. · Jan 2003
UTERINE TENACLUM HOOK
K001818 · Towne Brothers (Pvt.), Ltd. · Aug 2000

FDA 510(k) Resources - Obstetrics & Gynecology

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.

K060573 · BURBANK TENACULUM
Download PDF FDA Summary Vascular Control Syst…